Nov 21, 2024   SOURCE: PR NewsWire

I-Mab to Participate at the Piper Sandler Healthcare Conference

The 36(th) Annual Healthcare Conference will be held in New York, December 3-5, 2024

ROCKVILLE, Md., Nov. 21, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB, the "Company"), a U.S.-based global biotech company, exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer, today announced that management will present at the Piper Sandler 36th Annual Healthcare Conference on December 4, 2024.

Piper Sandler 36th Annual Healthcare Conference Presentation Details


            Presentation Time 
     Wednesday, December 4 at 4:30 p.m. ET



            Presenters        
     Sean Fu, PhD, MBA, Chief Executive Officer

                                 Phillip Dennis, MD, PhD, Chief Medical Officer



            Webcast link      
     
              Here



            Meetings            One-on-one and small group meetings: December 3 -
                                  4, 2024



            Management        
     Sean Fu, PhD, MBA, Chief Executive Officer
    Participants
                               
     Joseph Skelton, Chief Financial Officer

                                 Phillip Dennis, MD, PhD, Chief Medical Officer

                                 Tyler Ehler, Senior Director, Investor Relations

The webcast will also be available under "Event Calendar" on I-Mab's IR website
at https://ir.i-mabbiopharma.com/

For more information, please contact your Piper Sandler representative.

About I-Mab

I-Mab (NASDAQ: IMAB) is a US-based, global biotech company, exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer. I-Mab has established operations in Rockville, Maryland, and Short Hills, New Jersey. For more information, please visit https://www.i-mabbiopharma.com and follow us on LinkedIn and X.

For more information, please contact:

Tyler Ehler
Senior Director, Investor Relations
IR@imabbio.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/i-mab-to-participate-at-the-piper-sandler-healthcare-conference-302312202.html

SOURCE I-Mab Biopharma